Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Yield10 Bioscience (Nasdaq: YTEN) has announced its participation in the Benzinga Global Small Cap Conference on December 9, 2021. President and CEO Oliver Peoples, Ph.D. will present at 10:30 AM EST, followed by one-on-one meetings with registered investors. An archived replay of the presentation will be accessible via the conference website. Yield10 focuses on agricultural bioscience, utilizing its Trait Factory platform to develop superior Camelina varieties and high-value genetic traits for various crops.
Details
News Market Reaction – YTEN
The recorded move for YTEN in the trading session of this news was +5.91%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WOBURN, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that management will participate at the Benzinga Global Small Cap Conference on December 9, 2021.
President and Chief Executive Officer Oliver Peoples, Ph.D. will deliver his presentation at 10:30 AM EST on Thursday, December 9, 2021. Dr. Peoples will also be available to participate in one-on-one meetings with investors who are registered to attend the conference. An archived replay of the presentation will be available via the conference website.
Investors can register for the conference here:
https://www.benzinga.com/events/small-cap/december-2021-global/
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties for the production of proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina for the production of feedstock oils, nutritional oils, and PHA bioplastics, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn.
Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR
Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.